⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6708557 | 0.78 | — | — | |
| SCHEMBL28953753 | 0.70 | — | — | |
| SCHEMBL28827891 | 0.68 | — | — | |
| SCHEMBL27479690 | 0.68 | TDP1 (0.33) | — | |
| SCHEMBL28810974 | 0.68 | PTPN1 (0.37) | — | |
| SCHEMBL4308432 | 0.68 | — | — | |
| SCHEMBL4819249 | 0.66 | — | — | |
| SCHEMBL2026910 | 0.64 | — | — | |
| SCHEMBL29229638 | 0.64 | — | — | |
| SCHEMBL17512953 | 0.64 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9828335-B2 | Nitrone compounds and their use in personal care | DOW GLOBAL TECHNOLOGIES LLC (US) | 2017-11-28 | — | — | US | disclosed |
| US-20170253558-A1 | NITRONE COMPOUNDS AND THEIR USE IN PERSONAL CARE | DOW GLOBAL TECHNOLOGIES LLC | 2017-09-07 | — | — | US | disclosed |
| US-9701625-B2 | Nitrone compounds and their use in personal care | DOW GLOBAL TECHNOLOGIES LLC (US) | 2017-07-11 | — | — | US | disclosed |
| EP-3114110-A1 | NITRONE COMPOUNDS AND THEIR USE IN PERSONAL CARE | Dow Global Technologies LLC (US) | 2017-01-11 | — | — | EP | disclosed |
| US-20160362361-A1 | NITRONE COMPOUNDS AND THEIR USE IN PERSONAL CARE | DOW GLOBAL TECHNOLOGIES LLC | 2016-12-15 | — | — | US | disclosed |
| WO-2015134688-A1 | NITRONE COMPOUNDS AND THEIR USE IN PERSONAL CARE | DOW GLOBAL TECHNOLOGIES LLC (US) | 2015-09-11 | — | — | WO | disclosed |